Skip to content

Author

R. de la Harpe

We have 2 of 45 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Comparative evaluation of genotyping and low-pass sequencing for pharmacogenetic variant and phenotype inference

Overall, LP-WGS provides broader variant coverage and improved resolution for selected pharmacogenes but did not resolve all clinically important loci, and these findings support further evaluation of LP-WGS as a scalable PGx screening approach, especially where long-term genomic data reuse is a priority.

F. Hodel, C. Thorball, D. Haefliger et al. · 0 citations
Open access Jul 2026

Cardiovascular-Kidney-Metabolic Syndrome and Long-Term Risk of Cardiovascular Disease and all-cause Mortality.

KM stages were associated with a stepwise increase in risk of CVD and all-cause mortality, with important sex-specific differences observed particularly for all-cause mortality, and support the relevance of CKM staging for cardiovascular risk stratification and prevention in the general population.

N. Ahanchi, R. de la Harpe, B. Delabays et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.